company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4448000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4448000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,148000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,92000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13093000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8405000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8405000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8409000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4538000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4538000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,407000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-562000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4199000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4199000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1243000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,37000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1206000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1206000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7497000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7497000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,335000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6041000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-38000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,168000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,130000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,130000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q1,2013-01-01,2013-03-31,2014-05-13 18:40:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12934000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2212000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2212000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,184000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,615000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15248000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16661000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16661000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-190000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-190000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1998000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82491000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80493000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80493000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,63642000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,171000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,869000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,320000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8344000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8344000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-773000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-770000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-770000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9114000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15930000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15930000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-32804000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15705000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15705000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-40000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,134000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,94000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,94000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16011000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,8000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6884000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1463000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17127000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,11875000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,11875000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-316000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-316000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-316000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-468000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,101484000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,650000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,101666000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,101935000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q1,2014-01-01,2014-03-31,2014-05-13 18:40:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,113494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13386000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,193000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1632000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4352000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7209000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7209000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-508000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-508000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-508000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,531000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7186000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q2,2014-04-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,241000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19700000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,186000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1583000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1133000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19064000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19064000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,253000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1014000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1267000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1267000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18203000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-241000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15035000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15035000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2188000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8312000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20965000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20965000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-986000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-986000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-986000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,377000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21574000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,963000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61326000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,260000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42422000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4067000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22711000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22711000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-40000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40163000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40163000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,55000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,117299000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,99000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,117283000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,117283000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 06:51:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,54409000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25759000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,393000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2494000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1794000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21078000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21078000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-66000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-66000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13335000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13335000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7809000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,405000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2855000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12278000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7527000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7527000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,41000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,197000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,660000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,729000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,729000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6757000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22226000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,361000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2051000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1843000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21609000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21609000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-132000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,121000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-11000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-11000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-21615000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22879000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,389000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2373000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5329000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25446000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25446000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-70000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-135000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-374000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130217000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,141000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,129849000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,129849000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 06:07:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,104333000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27981000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-27000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2753000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,149000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24704000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-199441000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-199690000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-199690000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-139000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1357000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1218000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1218000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-223176000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24336000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,398000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-25000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2717000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3999000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25245000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25245000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-101000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12685000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14350000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1564000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1564000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-142000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,224000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,147000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,229000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,229000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-23452000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35016000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,400000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2725000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10914000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20976000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20976000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-204000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17761000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,50747000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,32782000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,32782000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-145000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-109000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,371000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-56000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,61000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,61000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11867000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32522000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,411000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-18000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2757000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3863000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33235000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33235000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-118000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40785000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58200000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17297000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17297000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-150000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1933000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,641000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2424000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 07:16:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13514000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28024000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,413000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-51000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3021000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6728000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17913000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17913000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-565000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40061000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82352000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,41726000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,41726000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-153000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,487000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,335000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,335000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,24148000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37597000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,406000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-86000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2895000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4511000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38893000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38893000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-54000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34723000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,51917000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17140000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17140000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-157000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,151665000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1510000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,153018000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,153018000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,131265000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,33000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36166000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36166000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,409000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,420000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2758000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2187000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30392000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30392000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-247000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10787000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48201000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37167000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37167000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-160000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-388000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,643000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,95000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,95000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6870000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34065000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,361000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-106000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2887000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,582000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30341000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30341000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-108000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100763000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32988000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-67883000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-67883000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,459000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1500000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1849000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1849000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 06:46:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-96375000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29128000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,221000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-459000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8576000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5054000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32888000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32888000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64925000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35346000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29580000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29580000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,104000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,85000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,85000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-62383000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37492000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,222000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-479000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15203000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13272000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35818000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35818000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-32101000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65796000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,33652000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,33652000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,320000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,219000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,539000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,539000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1627000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22945000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22945000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,248000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-512000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2490000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1834000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22553000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22553000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-147000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100881000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,62233000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38795000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38795000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-260000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,81938000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,81740000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,81740000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20392000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29339000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29339000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,207000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-690000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3191000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4931000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31562000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31562000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-173151000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100720000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-72452000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-72452000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,37432000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,123374000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,886000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,161692000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,161648000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q1,2019-01-01,2019-03-31,2020-05-04 06:59:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,57634000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48465000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,209000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1069000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4713000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2721000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-41891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-41891000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-169000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-124753000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,67828000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57094000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57094000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,612000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-98373000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,45000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36089000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,210000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-948000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3659000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5063000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38231000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38231000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-233000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45269000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,131768000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,86266000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,86266000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,543000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48578000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56402000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,214000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-431000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6767000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14368000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35484000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35484000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-171000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-161808000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,119939000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42040000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42040000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1666000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-284000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25000000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-1000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-284000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,100210000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122975000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,123543000.0
Epizyme Inc,EPZM,549300TNFWF88O4U4605,0001571498,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46019000.0
